Polymer Carriers
Polymer Carriers - Related Videos
01:24
Electron Carriers
0 Views •
2019
Electron carriers can be thought of as electron shuttles. These compounds can easily accept electrons (i.e., be reduced) or lose them (i.e., be oxidized). They play an essential role in energy production because cellular respiration is contingent on the flow of electrons. Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
02:34
Polymers
0 Views •
2020
The word polymer is derived from the Greek words “poly” which means “many” and “mer” which means “parts”. Polymers are long chains of molecules composed of repeating units of smaller molecules, known as monomers. They either occur naturally, such as DNA and proteins, or can be constructed synthetically, like plastics. They have varied structural characteristics, such as linear chains, branched chains, or complex networks, that contribute to the properties that they exhibit. Additionally,...
08:44
Tension Tests of Polymers
0 Views •
2023
Source: Roberto Leon, Department of Civil and Environmental Engineering, Virginia Tech, Blacksburg, VA Polymeric materials are widely used in civil structures, with uses ranging from very soft sealants to more rigid pipes in water and wastewater systems. The most basic definition of a polymer is a molecular structure with repeating subunits. The term polymer comes from Greek, where "poly" means many, and "-mer" means basic unit. Monomers, or single mers, are the specific repeating units. With...
01:21
Carrier Transport
0 Views •
2024
The generation of electrical current in semiconductors is fundamentally driven by two mechanisms: drift and diffusion. These processes are essential for the functionality and performance of semiconductor-based devices. Drift Current: The drift of charge carriers is started by an external electric field (E). Charged particles, such as electrons and holes, experience an acceleration between collisions with lattice atoms. For electrons, this results in a drift velocity (vd) given by: Where μe is...
13:29
Biodistribution of Nano-drug Carriers: Applications of SEM
0 Views •
2023
Source: Peiman Shahbeigi-Roodposhti and Sina Shahbazmohamadi, Biomedical Engineering Department, University of Connecticut, Storrs, Connecticut Nanoparticles have been increasingly used research towards targeted drug delivery and controlled drug release. While most of these particles have been developed as polymeric or liposomal particles because of their biocompatibility, there is a trend in current research toward the use of metallic and magnetic nanoparticles. These metallic nanoparticles...
FAQs
These properties influence how the carrier behaves in the body, including its stability, degradation, and release characteristics. Molecular weight can be selected as part of a design strategy, while chemical composition helps determine interactions with therapeutic payloads and physiological conditions. Together, they affect whether delivery is sustained, responsive, or suitable for a particular clinical goal.
A responsive carrier can use physiological conditions to regulate when its payload becomes available rather than releasing it without regard to the surrounding environment. This approach is important when the research goal requires controlled timing or condition-dependent delivery. It complements sustained-release designs and expands how polymer properties can be matched to a clinical objective.
Controlled release can help make treatment available in a more managed pattern, while concentration at target tissues may reduce exposure to healthy cells. This matters clinically because delivery design is not only about carrying a payload; it also concerns where and when that payload becomes available. The intended outcome is improved selectivity of exposure.
Sustained release is intended to extend the period over which treatment becomes available, whereas stimulus-responsive release links availability to physiological conditions. The distinction gives researchers two ways to regulate exposure: maintaining delivery over time or using a condition-dependent trigger. Selecting between them depends on the desired release behavior and the clinical objective.
Clinical translation depends on more than delivery performance. Researchers need to examine safety, biodegradability, stability, and clearance because these properties influence whether a formulation can remain reliable and be removed appropriately after administration. These considerations help determine whether a polymer carrier is suitable for continued clinical development, alongside its ability to protect payloads and regulate availability.
The platform can be adapted to carry small-molecule drugs, proteins, nucleic acids, or imaging agents. This breadth matters because each payload type creates a different delivery objective, such as protecting a fragile therapeutic or enabling controlled availability. Consequently, polymer-carrier research can address drug treatment and imaging needs within the same general design framework.
Clinical research applies these formulations across cancer therapy, vaccines, and chronic disease treatment. Their relevance comes from combining controlled availability with the possibility of concentrating treatment at target tissues and reducing exposure to healthy cells. The same principles can therefore support different clinical goals, from targeted treatment strategies to longer-lasting delivery.